BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 22280230)

  • 21. Significance of prophylactic modified radical neck dissection for patients with low-risk papillary thyroid carcinoma measuring 1.1-3.0 cm: first report of a trial at Kuma Hospital.
    Ito Y; Tsushima Y; Masuoka H; Yabuta T; Fukushima M; Inoue H; Tomoda C; Kihara M; Higashiyama T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
    Surg Today; 2011 Nov; 41(11):1486-91. PubMed ID: 21969150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Candidates for limited lateral neck dissection among patients with metastatic papillary thyroid carcinoma.
    Kang BC; Roh JL; Lee JH; Cho KJ; Gong G; Choi SH; Nam SY; Kim SY
    World J Surg; 2014 Apr; 38(4):863-71. PubMed ID: 24337241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radio-guided selective compartment neck dissection improves staging in papillary thyroid carcinoma: a prospective study on 345 patients with a 3-year follow-up.
    Carcoforo P; Portinari M; Feggi L; Panareo S; De Troia A; Zatelli MC; Trasforini G; Degli Uberti E; Forini E; Feo CV
    Surgery; 2014 Jul; 156(1):147-57. PubMed ID: 24929764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extranodal extension of metastatic papillary thyroid carcinoma: correlation with biochemical endpoints, nodal persistence, and systemic disease progression.
    Lango M; Flieder D; Arrangoiz R; Veloski C; Yu JQ; Li T; Burtness B; Mehra R; Galloway T; Ridge JA
    Thyroid; 2013 Sep; 23(9):1099-105. PubMed ID: 23421588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer.
    Ruel E; Thomas S; Dinan MA; Perkins JM; Roman SA; Sosa JA
    Endocrine; 2016 Jun; 52(3):579-86. PubMed ID: 26708045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roles of ultrasonography and computed tomography in the surgical management of cervical lymph node metastases in papillary thyroid carcinoma.
    Lee DW; Ji YB; Sung ES; Park JS; Lee YJ; Park DW; Tae K
    Eur J Surg Oncol; 2013 Feb; 39(2):191-6. PubMed ID: 22863305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcome of comprehensive central compartment dissection in patients with recurrent/persistent papillary thyroid carcinoma.
    Clayman GL; Agarwal G; Edeiken BS; Waguespack SG; Roberts DB; Sherman SI
    Thyroid; 2011 Dec; 21(12):1309-16. PubMed ID: 22136266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin.
    Hughes DT; Miller BS; Cohen MS; Doherty GM; Gauger PG
    Ann Surg Oncol; 2014 May; 21(5):1647-52. PubMed ID: 24385210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrometastasis in Papillary Thyroid Cancer Patients is Associated with Higher Recurrence in Lateral Neck Nodes.
    Kim SY; Kim BW; Pyo JY; Hong SW; Chang HS; Park CS
    World J Surg; 2018 Jan; 42(1):123-129. PubMed ID: 28779384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Total thyroidectomy with therapeutic level II-IV neck dissection for papillary thyroid carcinoma: level VI recurrence patterns.
    Carmel-Neiderman NN; Duek I; Amsterdam D; Wengier A; Kuzmenko B; Ringel B; Warshavsky A; Shapira U; Horowitz G; Izkhakov E; Fliss DM
    Eur Arch Otorhinolaryngol; 2020 Dec; 277(12):3449-3455. PubMed ID: 32488373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Analysis of the patterns of cervical lymph node recurrence in patients with cN0 papillary thyroid carcinoma after central neck lymph node dissection].
    Huang H; Xu Z; Wang X; Wu Y; Liu S
    Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):771-5. PubMed ID: 26813598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Routine central lymph node dissection with total thyroidectomy for papillary thyroid cancer potentially minimizes level VI recurrence.
    Hall CM; Snyder SK; Maldonado YM; Lairmore TC
    Surgery; 2016 Oct; 160(4):1049-1058. PubMed ID: 27521047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Excellent prognosis of patients with solitary T1N0M0 papillary thyroid carcinoma who underwent thyroidectomy and elective lymph node dissection without radioiodine therapy.
    Ito Y; Masuoka H; Fukushima M; Inoue H; Kihara M; Tomoda C; Higashiyama T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
    World J Surg; 2010 Jun; 34(6):1285-90. PubMed ID: 20041244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrence of papillary thyroid carcinoma with lateral cervical node metastases: Predictive factors and operative management.
    Chéreau N; Buffet C; Trésallet C; Tissier F; Leenhardt L; Menegaux F
    Surgery; 2016 Mar; 159(3):755-62. PubMed ID: 26435440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is routine dissection of level II-B and V-A necessary in patients with papillary thyroid cancer undergoing lateral neck dissection for FNA-confirmed metastases in other levels.
    Farrag T; Lin F; Brownlee N; Kim M; Sheth S; Tufano RP
    World J Surg; 2009 Aug; 33(8):1680-3. PubMed ID: 19506945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
    Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
    J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma.
    Baek SK; Jung KY; Kang SM; Kwon SY; Woo JS; Cho SH; Chung EJ
    Thyroid; 2010 Feb; 20(2):147-52. PubMed ID: 19785522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic impact of incomplete surgical clearance of radioiodine sensitive local lymph node metastases diagnosed by post-operative (124)I-NaI-PET/CT in patients with papillary thyroid cancer.
    Sabet A; Binse I; Grafe H; Ezziddin S; Görges R; Poeppel TD; Bockisch A; Rosenbaum-Krumme SJ
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1988-94. PubMed ID: 27118127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrence and Complications in Pediatric and Adolescent Papillary Thyroid Cancer in a High-Volume Practice.
    Rubinstein JC; Herrick-Reynolds K; Dinauer C; Morotti R; Solomon D; Callender GG; Christison-Lagay ER
    J Surg Res; 2020 May; 249():58-66. PubMed ID: 31923715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cervical Lymph Node Metastases of Papillary Thyroid Carcinoma, in the Central and Lateral Compartments, in Children and Adolescents: Predictive Factors.
    Spinelli C; Tognetti F; Strambi S; Morganti R; Massimino M; Collini P
    World J Surg; 2018 Aug; 42(8):2444-2453. PubMed ID: 29383423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.